SHELBY CRUMP: Open Payments
NPI 1285240887 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 10 payments from 8 companies in 2025. Trend: 2023 $42 · 2024 $0 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $40 |
| ARGENX US, INC. | 2 | $37 |
| Medtronic, Inc. | 1 | $25 |
| GE HEALTHCARE | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| SK Life Science, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
Products named: CATALYFT PL EXPANDABLE INTERBODY SYSTEM, VYVGART HYTRULO, AUSTEDO XR, WAINUA, VYEPTI, VYVGART.
Industry payments across CA — which companies pay providers there.
